共查询到20条相似文献，搜索用时 359 毫秒
1.
Castrucci G Frigeri F Salvatori D Ferrari M Sardonini Q Cassai E Lo DM Rotola A Angelini R 《Comparative immunology, microbiology and infectious diseases》2002,25(1):29-41
Eight separate, but related experiments, were carried out in which groups of six calves were vaccinated with one of eight commercial vaccines. In each experiment the vaccinated calves were subsequently exposed to three calves infected with virulent bovine herpesvirus-1 (BHV-1). In each experiment, all infected donor calves developed a typical severe infectious bovine rhinotracheitis (IBR) infection and excreted virus in their nasal secretions of up to 10(8.00) TCID50/0.1 ml. One live BHV-1 gE-negative vaccine (A) and three modified live vaccines (B, C, D), administered intranasally, all protected against clinical disease. The calves vaccinated with one vaccine (C) also did not excrete virus in the nasal secretions, whereas the calves protected by vaccines A, B and D excreted virus in their nasal secretions but at low titres (10(0.66)-10(1.24) TCID50/0.1 ml). A fourth modified live vaccine (E), given intramuscularly, failed to prevent mild clinical disease in the calves which also excreted virus in the nasal secretions at titre of 10(1.00) TCID50/0.1 ml. An analogous result was given by the calves vaccinated with either of the two inactivated vaccines (F and G) or with a BHV-1 subunit vaccine (H). All calves developed mild clinical signs and excreted virus at titres of 10(2.20)-10(3.12) TCID50/0.1 ml. Calves vaccinated with C vaccine were subsequently given dexamethasone, following which virus was recovered from their nasal secretions. The virus isolates did not cause disease when calves were infected and appeared to be closely related to the vaccine strain. 相似文献
2.
The use of gl deleted live vaccines against Aujeszky's disease (AD) facilitates to differentiate vaccinated from field-virus infected animals. In this study different modes of vaccination were tried to find out how sheep can be protected from a lethal infection with ADV. It could clearly be demonstrated that Aujeszky disease virus (ADV) is spread by horizontal transmission from infected pigs to sheep. The nasal discharges of infected pigs contained a maximum of 10(8.75)TCID50/g mucus at days 3 and 4 p.i. and those of the contact-pigs 10(8.5)TCID50/g mucus at days 6 and 7 after contact. Non-vaccinated contact sheep were infected horizontally by the pigs. The highest titres ranged from 10(6.25) to 10(7.5)TCID50/g mucus. These animals were sacrificed at day 5 p.i. exhibiting acute symptoms of AD. The nasal discharge of vaccinated sheep contained much lower amounts of ADV (maximum: 10(4.25)TCID50/g mucus). All surviving animals had developed antibodies. Following challenge with the ADV-strain NIA3, no febrile response or virus-shedding was observed in sheep vaccinated 2x s.c. or 2x i.m. with a gl deleted live vaccine, whereas sheep, vaccinated only 1x i.m. (4 out of 4 animals) or 1x i.m. (3 out of 4 animals) or 1x i.n. and 1x i.m. (1 out of 4 animals) had to be sacrificed after showing acute symptoms of AD. In conclusion it can be stated that a double parental vaccination with a gl deleted live vaccine protects sheep against a field-virus AD infection. 相似文献
3.
Four-week-old poults obtained from avian pneumovirus (APV) antibody-free parents were vaccinated with different serial 10-fold dilutions of cell culture-propagated APV vaccine. The birds were vaccinated with 50 microl into each conjunctival space and nostril (total of 200 microl). Each poult of each group was vaccinated in groups that received doses of 4 x 10(4), 4 x 10(3), 4 x 10(2), 4 x 10(1), or 4 x 10(0) 50% tissue culture infective dose (TCID50) of APV vaccine, respectively. Respiratory signs were seen between 3 and 12 days postvaccination (PV) in the poults that were vaccinated with 4 x 10(4), 4 x 10(3), and 4 x 10(2) TCID50, respectively. In these groups, APV was detected from swabs collected at 5 days PV and seroconversion was detected at 2 wk PV. The groups that were originally vaccinated with 4 x 10(1) and 4 x 10(0) TCID50 developed mild clinical signs after vaccination, but neither virus nor antibody was detected PV. At 2 wk PV (6 wk of age), birds from each group, along with five unvaccinated controls, were challenged with APV. Upon challenge, the 4 x 10(4) and 4 x 10(3) TCID50 groups were protected against development of clinical signs and were resistant to reinfection. The group previously vaccinated with 4 x 10(2) TCID50 developed clinical signs after challenge that were considerably milder than those seen in the groups that had previously been vaccinated with lower doses or no virus. Even though 4 x 10(2) TCID50 vaccine dose administered by intranasal ocular route resulted in infection, incomplete protection resulted with this pivotal dose. Upon challenge, the 4 x 10(1) and 4 x 10(0) TCID50 groups exhibited milder disease signs than those seen in the challenged unvaccinated controls. In these groups, APV was detected in preparations of swabs collected at 5 days postchallenge (PC) and seroconversion was detected at 2 wk PC. These results indicate that the dose of APV vaccine that causes protection is higher than that required to produce infection. 相似文献
4.
Ariyoshi R Takase K Matsuura Y Deguchi K Ginnaga A Fujikawa H 《The Journal of veterinary medical science / the Japanese Society of Veterinary Science》2003,65(10):1127-1130
The oral vaccination against Fowlpox was investigated via drinking water containing the F132-c strain of Fowlpox virus to be effective even though the vaccine virus-titer was 10(4) TCID (50)/dose each time. When the virus-titer of the F132-c strain was 10(4-5 )TCID(50)/dose per single drinking water vaccination, 90% or more of chickens were not protected, however, they were protected when vaccinated twice via drinking water. A weak immune response occurred by a slight infection after the first vaccination, and due to memory cells, a booster could work well after the second vaccination. These results suggest the possibility of reducing both the amount of virus required for a vaccine via drinking water and the labor cost in the field. 相似文献
5.
A comparison of intradermal (ID) versus intramuscular (IM) routes of pig vaccination with deleted Aujeszky's disease (AD) vaccine on the formation of specific postvaccinal and postchallenge humoral immune response was performed. The studies were carried out on 21 eight week-old piglets, divided into three groups--two experimental and one control of 7 piglets each. Animals of first two groups were vaccinated twice in 12 and 16 week of age with deleted, live attenuated AD vaccine Porcilis Begonia (Intervet). Group I was vaccinated with a dose of 2.0 ml (10(6.0) TCID50)) intramuscularly (IM) into neck muscles, and group II received 0.2 ml (10(5.0) TCID50) intradermally (ID) in neck area using needleless apparatus SERENA model SD 1-2 (Emplast, Italy). In group K (control) 2.0 ml PBS IM was used. Seventy days after the first vaccination all pigs were intranasally infected with a dose of 10(5.5) TCID50 of virulent Northern Ireland Aujeszky-3 (NIA-3) strain of Herpesvirus suis type 1 (SHV-1) by instilling 0.5 ml of virus suspension into each nostril. Specific humoral immune response was evaluated using seroneutralization (SN) test and gE-ELISA-Pseudorabies virus gpI Antibody Test Kit (Herd Chek Anti-PRV gpI), IDEXX Lab Inc (USA). It was found that challenge caused anamnestic reaction in both groups of vaccinated pigs, but postchallenge immune response was stronger in ID-vaccinated group--on 14 day post infection (dpi) SN antibody level was considerably higher than in IM-vaccinated group. The obtained results suggest that secondary immunological response after challenge is decidedly more effective in the range of evaluated parameters in animals vaccinated by ID route, which can be linked to, perhaps underestimated yet and seldom utilized, skin immunity mechanisms in specific prophylaxis of infectious diseases. Advantages and disadvantages of SN test and ELISA are also discussed. 相似文献
6.
羊痘病毒G蛋白偶联趋化因子受体基因序列分析及其在鉴别病毒种属上的作用 总被引：1，自引：0，他引：1
为明确G蛋白偶联趋化因子受体(GpCR)基因在羊痘病毒种属鉴别中的作用,本实验对3株绵羊痘病毒(SPV)和2株山羊痘病毒(GPV)弱毒疫苗株的GpCR进行了克隆测序,并与GenBank中登录的21个羊痘病毒属成员相关序列进行了比对。核酸同源性分析表明SPV不同毒株之间同源性达到99.5%～99.8%;GPV之间同源性达到98.8%～99.8%;GenBank上公布的疙瘩皮肤病病毒(LSDV)之间同源性达到100%。而GPV、SPV和皮肤疙瘩病毒两两比对的同源性仅达到94.2%～95.9%。对GpCR的系统进化树分析可以看出GPV、SPV和LSDV分别位于不同的进化分枝上,而GPV与LSDV具有更近的亲缘关系。GpCR基因在鉴别GPV属和流行病学分析中具有重要价值。 相似文献
7.
Savini G Ronchi GF Leone A Ciarelli A Migliaccio P Franchi P Mercante MT Pini A 《Veterinary microbiology》2007,124(1-2):140-146
Because no suitable products are at the moment available to safely control the spread of BTV-16 in Europe, an inactivated vaccine was produced from the reference field isolate of bluetongue virus serotype 16. One group of six sheep was vaccinated subcutaneously with the inactivated vaccine twice, on days 0 and 28, whereas a second group of eight sheep was inoculated with saline solution and used as mock-vaccinated control animals. Seventy-eight days after the first vaccination, all sheep were inoculated subcutaneously with a suspension containing 10(6.3) TCID(50) of a virulent reference BTV-16 isolate. Apart from a transient inflammatory reaction at the injection site, no adverse effects were reported following vaccination. All vaccinated animals developed high titres (7.3-9.3log(2)(ED50%/50 microl)) of virus-specific neutralising antibodies and were resistant to challenge with BTV-16. Conversely, following challenge, control animals developed hyperthermia and long lasting high-titre viraemia. 相似文献
8.
Evaluation in swine of a subunit vaccine against pseudorabies 总被引：2，自引：0，他引：2
A subunit vaccine against pseudorabies virus (PRV) was prepared by treating a mixture of pelleted virions and infected cells with the nonionic detergent Nonidet P-40 and emulsifying the extracted proteins incomplete Freund's adjuvant. Three 7-week-old pigs without antibodies against PRV were given 2 IM doses of this vaccine 3 weeks apart. Thirty days after the 2nd vaccination, 10(6) median tissue culture infective doses (TCID50) of a virulent strain of PRV were administered intranasally. Tonsillar and nasal swabs were collected daily between 2 and 10 days after challenge exposure. The pigs vaccinated with the subunit vaccine were not found to shed virulent PRV. Two groups of five 7-week-old pigs vaccinated with commercially available vaccines, either live-modified or inactivated virus, and subsequently exposed to 10(6) TCID50 of virulent PRV, shed virulent virus for up to 8 days. The subunit vaccine induced significantly higher virus-neutralizing antibody titers than either the live-modified or inactivated virus vaccine. 相似文献
9.
10.
将重组鸡痘病毒vFV282疫苗用生理盐水作10^-1，10^-2，10^-3，10^-4系列稀释，分别免疫7天龄鸡，于免疫后21d，分别用NDV、IBDV和FPV攻毒，观察其保护率，结果除NDV攻毒在10^-4组保护率为40％（4／10），其余各组均为100％（10／10）保护。表明该疫苗的最小免疫剂量≤10^-3TCID50/0.02mL。 相似文献
11.
Effects of various environments on the infectivity of canine parvovirus-2 (CPV-2) were studied. When CPV-2 was subjected to several controlled indoor environments, the virus remained infective at approximate initial inoculation amount (median tissue culture infective dose [TCID50] = 10(5.5)/ml) for 12 months at temperatures less than -20 C, decreased to TCID50 of 10(2.3)/ml by 12 months at 4 C, and had a TCID50 of less than 10(1)/ml at room temperature (20 C) or higher in less than 2 months. The CPV-2 subjected to outdoor environments was not infective beyond 5 months, except that kept in areas protected from sunlight and drying conditions. The virus surviving in the outdoor environments was not infective for study dogs, whereas the virus maintained at less than 20 C was. 相似文献
12.
本研究使用不同孔径的陶瓷(有机)膜过滤器,对不合格的猪伪狂犬病毒细胞收获液(病毒含量≤104TCID50/mL)滤除杂蛋白、超滤浓缩、除菌处理得到纯化浓缩的猪伪狂犬病疫苗病毒液;然后对纯化浓缩的猪伪狂犬病疫苗病毒液分别进行杂蛋白去除率检验与无菌检验、病毒含量测定、安全检验、效力检验;将检验合格的纯化浓缩的猪伪狂犬病疫苗病毒液添加保护剂冻干,并对纯化浓缩的猪伪狂犬病冻干活疫苗进行以上各项检验,以及进行免疫猪体内抗体消长变化的检测。结果表明:纯化的猪伪狂犬病疫苗杂蛋白去除率平均达到68.3%以上,病毒含量≥105TCID50/mL,效力检验合格;免疫猪体内抗猪伪狂犬病毒抗体增长幅度比同时期未纯化的常规疫苗显著,其中免疫至84 d时中和抗体效价平均高达40.35稀释倍数左右,比常规疫苗中和抗体效价平均高出14.22稀释倍数。此项研究为畜禽疫苗的纯化提供一定的参考。 相似文献
13.
Vaccination of sheep with cell culture grown orf virus 总被引：1，自引：0，他引：1
D PYE 《Australian veterinary journal》1990,67(5):182-186
Orf virus, derived from contagious pustular dermatitis (scabby mouth) lesions in sheep, was adapted to cell culture and subsequently evaluated as a potential vaccine for sheep. The traditional vaccine virus, prepared from the infected scabs of orf virus lesions in sheep, was used to vaccinate sheep by scratching with an applicator (mounted pins) dipped in virus. Less than 10 TCID50 (50% tissue culture infectious doses) of virus was required to produce large lesions (greater than 5 mm diameter) which developed during a period of 10 to 14 d prior to onset of healing which was complete by 28 to 30 d. A serum neutralising antibody response was also detected and protection against challenge by application of virulent virus to abraded skin was demonstrated in that challenge lesions developed and healed more quickly (14 d against 30 d). However, cell culture-adapted virus required more than 10(5) TCID50 to induce even small lesions (less than 2 mm diameter). An antibody response could not be detected and no evidence of protection against challenge with virulent virus was demonstrated. In contrast, a recent field isolate has yielded a cell culture-adapted virus preparation that readily infects sheep, produces large lesions, detectable antibody and protects against challenge. This isolate is distinct from the traditional vaccine strain on the basis of restriction enzyme analysis but provides cross-protection in sheep inmmunisation and challenge studies. These results demonstrate that a cell culture produced scabby mouth vaccine is feasible. 相似文献
14.
15.
Morioka K Fukai K Ohashi S Sakamoto K Tsuda T Yoshida K 《The Journal of veterinary medical science / the Japanese Society of Veterinary Science》2008,70(7):653-658
At least two biotypes were observed at the 2nd passage stage after the isolation of Foot-and-mouth disease Virus (FMDV) O/JPN/2000 strain. These 2 types of viruses differed from their plaque phenotypes and were distinguishable by using a monoclonal antibody (MAb) 64G8 that was made for the FMDV O/JPN/2000 strain. One of these 2 biotypes formed small plaque (SP) and with immuno staining showed a positive reaction to MAb 64G8, while the other formed clear large plaque (LP) and did not react with MAb 64G8. The amino acid sequences of the capsid coding region (VP1-VP4) of the SP virus (SPV) and the LP virus (LPV) revealed two substitutions on the 133rd amino acid in VP2, and the 56th amino acid in VP3. These amino acid changes of SPV and LPV are Asn to Asp, Arg to His, respectively. The Arg of the 56th amino acid in VP3 that have been known as critical position of cell culture adapted virus. Only LPV showed high pathogenicity in suckling mice, and its LD(50) was calculated to be about 10(2) TCID(50)/0.1 ml. These results showed that the SPV that existed at the 2nd passage stage from isolation was a low virulence virus, which may suggest why the pathogenicity of O/JPN/2000 did not show clear symptoms in infected cattle. 相似文献
16.
为建立羊痘病毒(CaPV)的环介导等温扩增(LAMP)检测方法,本研究根据GenBank中羊痘病毒的保守基因序列,设计出针对羊痘病毒的LAMP引物,利用LAMP Real Time Turbidimeter LA-320仪优化得到病毒核酸等温扩增最佳条件是62 ℃恒温反应60 min。在此条件下,病毒核酸的最低检测含量为3.1×10-2 pg/μL,灵敏度比OIE推荐的PCR方法高104倍。添加钙黄绿素(calcein)建立的目测法,还可实现对上述病原体检测结果肉眼观察。本研究获得的CaPV LAMP仪器法和目测法可特异性地扩增羊痘病毒属的山羊痘病毒、绵羊痘病毒及牛疙瘩皮肤病病毒核酸,具有反应快速、特异性强、灵敏度高、操作简便、设备要求低等特点。 相似文献
17.
A Zuffa A Brányik J Zuffová G Melcicky M Hirko J Blecha L Valent 《Veterinární medicína》1981,26(5):257-270
The experiments with sheep and young cattle were carried out to test the immunizing efficacy of inactivated adjuvant vaccine against Aujeszky's disease. The vaccine application at doses of 1 ml and 2 ml to lambs at the age of eight to ten months caused the neutralizing antibody production with a significant rise of titres after revaccination. A survival of infection induced with a dose of 10(5.5) TKID50 of virulent virus was recorded in 62.5% of once vaccinated animals and in 87.5% of twice vaccinated animals. When applying different doses of vaccines (from 1 to 10 ml) to young cattle, the antibody reaction level was directly dependent on the inoculum quantity. The double inoculation of animals with vaccines of 2 ml and 5 ml caused the neutralizing antibody production at titres of 1:35, or 1:46. The animals, immunized with the live or inactivated IBR-vaccine possessing high antibody titres against IBR-virus, reacted upon the vaccination with inactivated Aujeszky's vaccine anamnestically, by early production of antibodies in high titres. Metaphylactic vaccination (2 ml of vaccine) of cattle in herds with an acute course days, however earlier during five days from the revaccination when it was carried out in seven days following the first vaccination. 相似文献
18.
Okuda Y Kuroda M Ono M Chikata S Shibata I 《The Journal of veterinary medical science / the Japanese Society of Veterinary Science》2008,70(10):1017-1025
The objective of this study was to evaluate the influences of genetic and antigenic variations in field isolates of porcine reproductive and respiratory syndrome virus (PRRSV) on vaccine efficacy. Four-week-old pigs were vaccinated with a commercial modified live virus vaccine. Four weeks after vaccination, pigs in both the vaccinated group and the non-vaccinated group were challenged intranasally with 10(7) TCID(50) of PRRSV wt-11 (Experiment 1) or PRRSV wt-7 (Experiment 2). Based on genome sequencing of ORF5 and cross neutralization test results, PRRSV wt-11 is similar to the vaccine strain, whereas wt-7 is distinct from the vaccine strain. In the vaccinated challenged groups, clinical signs were less severe, the mean rate of weight gain was greater, and gross lung lesions were less severe when compared with the non-vaccinated challenged groups in both experiments. In Experiment 1, the virus was isolated from serum at 3 days post-challenge, and the mean virus titers in broncho-alveolar lavage fluids (BALF) and tissues were lower in pigs in the vaccinated challenged groups compared with those in the non-vaccinated challenged group. In Experiment 2, virus isolation from serum, BALF and tissues showed no significant differences between the groups. These results suggest that commercial PRRSV vaccine could be effective in reducing clinical disease following a challenge with field isolates of PRRSV. However, with regards to virological protection, the efficacy of the vaccine may be affected by the nature of the PRRSV isolates. 相似文献
19.
20.
伪狂犬病弱毒株的分离鉴定及生物学特性的研究 总被引：3，自引：1，他引：2
在流行病学调查中分离到1株病毒,经鉴定为伪狂犬病弱毒株,定名为F971株。分离病毒经克隆纯化后测得其毒价为10^7.59TCID50/ml,通过细胞中和试验表明分离病毒能也有效地被猪伪狂犬病毒闽A株阳性血清中和。病毒在电镜下可以清楚地观察到囊膜及外周纤突。分离株对3日龄乳鼠有一定的致病力,但对家兔、3日龄乳猪及妊娠母猪都有很高的安全性。用不同的剂量10^0、10^-1、10^-2肌肉注射3日龄乳猪后14天用10^5.7TCID50伪狂犬病强毒攻击,所有试验仔猪均得到保护。用分离株免疫母猪,其后代可获高滴度的母源抗体,15日龄的仔猪能抵御10^5.7TCID50强毒的攻击。用ELISA普查试剂盒测定免疫猪抗体,结果均为阳性,而用g^1-ELISA试剂盒测定抗体时,结果均为阴性。证明分离株具有缺损g^1糖蛋白的特性。综合上述特性,确定F971为1株g^1糖蛋白缺损的猪伪狂犬病弱毒株。 相似文献